The US FDA has approved the innovative ECG system HyperQ Analyzer Rest developed by Israeli biotech BSP. HyperQ can test patients at rest, diagnosing early-stage heart disease without putting the patient under stress. It is less risky than alternative invasive and radioactivity tests.
http://news.nocamels.com/2014/10/29/bsp-receives-fda-approval-for-hyperq-rest-system/